Sorriso Pharmaceuticals, a company focused on transforming anti-inflammatory antibody therapy, announced the company has closed on a $31 million Series A financing. The round...
Exopharm Limited has been granted US patent US 11202805 for its LEAP exosome purification technology. This patent positions Exopharm as a global leader in...
AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting COVID-19 diagnostics, oncological research, and dry eye...
Sandoz, a global leader in generic and biosimilar medicines, announced that it has submitted a Marketing Authorization Application for a proposed biosimilar trastuzumab (150...
Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is currently negotiating with the Joint Institute for Nuclear Research (JINR), an international intergovernmental scientific organization established by eleven founding...
